New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2014
05:15 EDTAGNAllergan issued third Restasis patent, says Citigroup
Citigroup says Allergan yesterday was issued a third Restasis patent by the USPTO, which extends through 2024 and was immediately submitted for Orange Book listing. Citi keeps a Buy rating on the stock with a $130 price target.
News For AGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for AGN

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use